Inform Genomics Files Provisional Patent Application with United States Patent and Trademark Office (USPTO) -"Systems and Methods for Predicting Treatment-Regimen-Related Outcomes."
05 oct. 2015 08h00 HE
|
Inform Genomics
Boston, Oct. 5, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a proprietary analytic platform to develop genomic-based, precision medicine products announced...
Inform Genomics Licenses Two US Patents from Taiwan's National Cheng Kung University to Advance Development of Precision Medicine Products
01 juin 2015 08h30 HE
|
Inform Genomics
Boston, MA, June 1, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a
proprietary analytic platform to develop genomic-based, precision
medicine products, and...
Inform Genomics Selects ICON as Contract Research Organization (CRO) for Pivotal Multicenter Study of HSCT/Mucositis Product Candidate
01 juin 2015 08h00 HE
|
Inform Genomics
Boston, MA, June 1, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a
proprietary analytic platform to develop genomic-based, precision
medicine products, today...
Inform Genomics Selects US Oncology Research as the Site Management Organization (SMO) for Pivotal Multicenter Study of OnPART
29 mai 2015 16h00 HE
|
Inform Genomics
Boston, MA, May 29, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a
proprietary analytic platform to discover and develop
genomic-based, precision medicine...
Inform Genomics Selects Vector Oncology as Contract Research Organization (CRO) for Pivotal Multicenter Study of OnPART
29 mai 2015 08h00 HE
|
Inform Genomics
Boston, MA and Memphis, TN, May 29, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a
proprietary analytic platform to develop genomic-based, precision
medicine...
Inform Genomics Announces Appointment of Carl de Moor, PhD, as Chief Technology Officer
28 juil. 2014 08h00 HE
|
Inform Genomics
Boston, MA, July 28, 2014 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc, a privately held company that utilizes a
proprietary technology platform to discover and develop
genomic-based, precision medicine...
Inform Genomics and Translational Drug Development (TD2) Announce Strategic Collaboration
23 juin 2014 07h00 HE
|
Inform Genomics
BOSTON, June 23, 2014 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a proprietary technology platform to discover and develop genomic-based, precision medicine...
INFORM GENOMICS and TESARO Enter Into Collaboration Agreement
15 oct. 2013 07h00 HE
|
Inform Genomics
Boston, MA, Oct. 15, 2013 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc., a private company focused on developing novel
platforms of genomic-based, personalized medicine products for
cancer supportive...
Inform Genomics Presents Biologic Validity for OnPART Predictive Networks Identifying Potential Genomic Targets for Drug Discovery
03 juin 2013 08h00 HE
|
Inform Genomics
Boston, MA, June 3, 2013 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc., a private company focused on developing novel
platforms of genomic-based personalized medicine products for
cancer supportive...
Inform Genomics Presents Results for OnPART(tm) Showing High Degree of Accuracy Predicting Six Common Side Effects of FOLFOX Chemotherapy for Colon Cancer
28 janv. 2013 07h00 HE
|
Inform Genomics
Boston, MA, Jan. 28, 2013 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc., a private company focused on developing novel
platforms of genomic-based personalized medicine products for
cancer supportive...